Editas Medicine EDIT has nominated EDIT-401 as its lead in vivo development candidate. The experimental, one-time gene editing therapy is designed to significantly reduce LDL cholesterol (LDL-C) ...

Kale, cabbage, onions, garlic and broccoli are some of the most nutritious foods out there, but have you ever wondered what makes them so healthy? In addition to vitamins, minerals and antioxidants, ...

Introduction Patients with coronary artery disease (CAD) have diminished tolerance for gastrointestinal endoscopy procedures (upper/lower) performed under deep sedation, resulting in increased ...

In a phase 3 trial of 133 patients with high-risk acute promyelocytic leukemia (APL), all-trans retinoic acid and arsenic trioxide (ATRA-ATO) therapy demonstrated superior 2-year event-free survival ...

Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University, 25-1 Shichiban-cho, Wakayama 640-8156, Japan ...

A Cary teenager received a $25,000 scholarship for developing a potentially effective treatment for cardiovascular disease. Jamie Cheng, 16, is one of 21 students nationwide to receive the Davidson ...

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the"Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline ...